The generic industry has greatly benefited from the increased investment in the sector in recent years. After the generic was first approved in 2000, investments in the sector has experienced strong growth, with both domestic and foreign players invest millions of dollars. As per a new research on the sector called "Brazil Generics Market Forecast for 2012" by RNCOS, the generics market in Brazil is expected to grow at a CAGR of around 19% in 2010-2012.
We have done extensive research and sound analysis of the generics market in Brazil to understand the factors that will continue to serve as growth propellers for the market in coming years. We have identified that various other factors, such as patent expiries, government initiatives, aging population and rising prescription rates have promoted the use of generics in the country, leading the market to witness a remarkable growth. The report also provides insight into the role as the country's legislative framework for the development of its generic drugs industry.
The report discusses the potential of generic drugs in various therapeutic segments in the pharmaceutical industry, which will give a clear idea of what type of products on the market. Apart from this report also discusses several sources in the industry bottlenecks hampering the growth of the generic industry in the country.
"Brazil Generics Market Forecast for 2012" contains an extensive research and conceptual study of the generics market in Brazil. It also covers various growth-supporting factors such as macroeconomic environment, market drivers and their impact and other factors supporting industry growth. The report thoroughly investigates the current market trends, industrial development and competitive landscape, so customers understand market structure and its progress in the coming years. Industry forecasts in the research report has been made carefully after considering all the possible post-recession impact on industry.
No comments:
Post a Comment